Next Article in Journal
Cardiac Extracellular Vesicles in Normal and Infarcted Heart
Next Article in Special Issue
Modulating Astrocyte Transition after Stroke to Promote Brain Rescue and Functional Recovery: Emerging Targets Include Rho Kinase
Previous Article in Journal
Anion Channel Inhibitor NPPB-Inhibited Fluoride Accumulation in Tea Plant (Camellia sinensis) Is Related to the Regulation of Ca2+, CaM and Depolarization of Plasma Membrane Potential
Previous Article in Special Issue
Innate Immunity and Inflammation Post-Stroke: An α7-Nicotinic Agonist Perspective
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessReview
Int. J. Mol. Sci. 2016, 17(1), 64;

Ischemia, Immunosuppression and Infection—Tackling the Predicaments of Post-Stroke Complications

Centre for Inflammatory Diseases, Department of Medicine, Monash Medical Centre, Monash University, Clayton, VIC 3168, Australia
Author to whom correspondence should be addressed.
Academic Editor: Chris Sobey
Received: 23 November 2015 / Revised: 14 December 2015 / Accepted: 24 December 2015 / Published: 5 January 2016
(This article belongs to the Special Issue The Immune System and Inflammation in Cerebral Ischemia)
Full-Text   |   PDF [411 KB, uploaded 5 January 2016]   |  


The incidence of stroke has risen over the past decade and will continue to be one of the leading causes of death and disability worldwide. While a large portion of immediate death following stroke is due to cerebral infarction and neurological complications, the most common medical complication in stroke patients is infection. In fact, infections, such as pneumonia and urinary tract infections, greatly worsen the clinical outcome of stroke patients. Recent evidence suggests that the disrupted interplay between the central nervous system and immune system contributes to the development of infection after stroke. The suppression of systemic immunity by the nervous system is thought to protect the brain from further inflammatory insult, yet this comes at the cost of increased susceptibility to infection after stroke. To improve patient outcome, there have been attempts to lessen the stroke-associated bacterial burden through the prophylactic use of broad-spectrum antibiotics. However, preventative antibiotic treatments have been unsuccessful, and therefore have been discouraged. Additionally, with the ever-rising obstacle of antibiotic-resistance, future therapeutic options to reverse immune impairment after stroke by augmentation of host immunity may be a viable alternative option. However, cautionary steps are required to ensure that collateral ischemic damage caused by cerebral inflammation remains minimal. View Full-Text
Keywords: stroke; immunosuppression; infection; antibiotics; clinical outcome stroke; immunosuppression; infection; antibiotics; clinical outcome

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Shim, R.; Wong, C.H.Y. Ischemia, Immunosuppression and Infection—Tackling the Predicaments of Post-Stroke Complications. Int. J. Mol. Sci. 2016, 17, 64.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top